Merck ends trial for oral Alzheimer’s candidate amid liver toxicity cases

 Merck (MRK) terminates a mid-stage trial for an oral Alzheimer's therapy due to concerns over liver toxicity.

https://seekingalpha.com/news/4024108-merck-ends-trial-alzheimers-drug-liver-toxicity